Back to Search
JOHN HERNDON, MD
MD
Anesthesiology Physician
NPI: 1689676744IndividualAccepts Medicare
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1987
Research & Publications (20)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Predictors of success on the American Board of Orthopaedic Surgery examination.
PMID 19557490·Clin Orthop Relat Res·2009
8-other
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
PMID 19514083·Cancer·2009
8-other
"Reproductive aging in captive and wild common chimpanzees: factors influencing the rate of follicular depletion," by S. Atsalis and E. Videan, American Journal of Primatology 71, 271-282 (2009).
PMID 19514043·Am J Primatol·2009
7-preclinical
Cancer surveillance behaviors and psychosocial factors among long-term survivors of breast cancer. Cancer and Leukemia Group B 79804.
PMID 19133656·Cancer·2009
8-other
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 12222 MERIT DR STE 600
DALLAS, TX 75284 - Phone
- (972) 715-5000
Quick Facts
- NPI
- 1689676744
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile